eMDI connected metered-dose inhaler

H&T Presspart, the world’s leading manufacturer of components for metered dose inhalers (MDIs), are pleased to announce they will be presenting at this year’s Connectivity in Medical Technology Conference on Thursday 22nd June.

The speech, on day 2 of the conference at 14.50pm, is entitled  ‘ Smart Inhalers- Improving Patient Adherence and Reducing Healthcare Costs’ and will be presented by Dana Shears, H&T Presspart’s Director of Sales for the Americas.

The speech at this year’s conference follows on from the launch at last year’s DDL exhibition of H&T Presspart’s eMDI smart connected inhaler. The eMDI is the first market-ready, fully-embedded, intuitive, connected metered dose inhaler which seamlessly integrates with the BreatheSmart app from Cohero Health.

A number of key areas will be covered by Mr Shear’s in his speech including:

  • Global health data confirms that poor patient adherence to long-term therapies, such as asthma and COPD, contribute significantly to rising healthcare cost.
  • Smart Inhalers are emerging which enable more effective monitory of patient compliance and adherence, including remotely.
  • Clinical studies using smart devices have demonstrated improvements and translate directly to a reduction in healthcare cost.
  • Smart inhalers face numerous challenges, from a wide range of stakeholders, for successful adoption on a global scale.

Connectivity in Medical Technology Conference is now in its third year and will feature a host of international expert speakers. The conference is aimed at all those with an interest in connected medical devices and medical mobile apps.eMDI smart inhaler

Please visit the H&T Presspart website for more information on the eMDI